3201 CARNEGIE AVENUE
CLEVELAND OH 44115-2634
Business Phone: 216-431-9900
• CLEVELAND, OH How do I update this listing?
Athersys, INC / NEW is based out of Cleveland. Athersys, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutic product candidates in multiple disease areas in the United States. Its product pipeline includes ATHX-105, a Phase I clinical trial product for the treatment of obesity. The company also develops orally active pharmaceutical products for the treatment of central nervous system disorders that include sleep disorders, such as narcolepsy or excessive daytime sleepiness; and other potential indications, such as attention deficit hyperactivity disorder and other cognitive disorders. In addition, Athersys, through its product co-development collaboration with Angiotech Pharmaceuticals, Inc., develops MultiStem for the treatment of damage caused by myocardial infarction and peripheral vascular disease, as well as for bone marrow transplant/oncology support, ischemic stroke, and other disease indications.Whalewisdom has at least 143 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2012-03-22. The notice included securities offered of Equity,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security